Meta-analysis of rare and adverse event data
- PMID: 19807443
- DOI: 10.1586/14737167.2.4.367
Meta-analysis of rare and adverse event data
Abstract
Potentially beneficial drugs may have side effects. Such adverse events may be serious but rare, making their effect difficult to quantify, or even their identification problematic within randomized controlled trials. Meta-analysis provides a means of combining such outcome data across a series of studies and provides a more powerful analysis than is possible from a single study. However, meta-analysis of adverse event data presents some unique methodological challenges. Procedural issues pertaining to study selection and the inclusion of both randomized and observational data are discussed. The statistical problem of combining rare outcomes is also considered at length. Model choice, continuity corrections, exact statistics, Bayesian methods and sensitivity analysis are all covered. The application of results from adverse event meta-analyses to clinical and economic decision models is also considered. A number of examples are presented to illustrate the key points.
Similar articles
-
Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: the case of rosiglitazone.Am Heart J. 2008 Jul;156(1):23-30. doi: 10.1016/j.ahj.2008.03.002. Epub 2008 May 5. Am Heart J. 2008. PMID: 18585493 Review.
-
Meta-analyses of safety data: a comparison of exact versus asymptotic methods.Stat Methods Med Res. 2009 Aug;18(4):421-32. doi: 10.1177/0962280208092559. Epub 2008 Jun 18. Stat Methods Med Res. 2009. PMID: 18562399
-
Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.Clin Trials. 2008;5(2):116-20. doi: 10.1177/1740774508090212. Clin Trials. 2008. PMID: 18375649
-
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data.Stat Med. 2004 May 15;23(9):1351-75. doi: 10.1002/sim.1761. Stat Med. 2004. PMID: 15116347
-
[Meta-analysis of the Italian studies on short-term effects of air pollution].Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71. Epidemiol Prev. 2001. PMID: 11515188 Italian.
Cited by
-
Measuring the impact of zero-cases studies in evidence synthesis practice using the harms index and benefits index (Hi-Bi).BMC Med Res Methodol. 2023 Mar 13;23(1):61. doi: 10.1186/s12874-023-01884-x. BMC Med Res Methodol. 2023. PMID: 36907858 Free PMC article.
-
Reporting Quality of Oral TCM Systematic Reviews Based on the PRISMA Harms Checklist from 2013 to 2020.Evid Based Complement Alternat Med. 2023 Jan 24;2023:4612036. doi: 10.1155/2023/4612036. eCollection 2023. Evid Based Complement Alternat Med. 2023. PMID: 36733845 Free PMC article.
-
Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis.Sci Rep. 2022 Sep 20;12(1):15698. doi: 10.1038/s41598-022-18353-y. Sci Rep. 2022. PMID: 36127353 Free PMC article.
-
Bayesian sparse modeling to identify high-risk subgroups in meta-analysis of safety data.Res Synth Methods. 2022 Nov;13(6):807-820. doi: 10.1002/jrsm.1597. Epub 2022 Aug 26. Res Synth Methods. 2022. PMID: 36054779 Free PMC article.
-
Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports.BMC Med. 2021 Aug 25;19(1):195. doi: 10.1186/s12916-021-02062-w. BMC Med. 2021. PMID: 34429113 Free PMC article.
LinkOut - more resources
Full Text Sources